CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016
Impel NeuroPharma raised $67.5M on 12/06/2018

Similar Companies

EndoChoice

EndoChoice Based in Atlanta GA, EndoChoice® is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice leverages its direct sales organization to serve more than 2,000 customers in the United States and works with 34 distribution partners world-wide. The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy® System (Fuse®). 2014 marked the fifth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine.

Visual Sonics

Visual Sonics is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Implant Direct, LLC

Implant Direct, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Perspectives International

Perspectives International is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medi part inc

medi part inc is a Cary, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.